aminolevulinic acid has been researched along with Erythroplasia in 12 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Erythroplasia: A condition of the mucous membrane characterized by erythematous papular lesions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The reported numbers of PMDS and HNSCC ranged between 5 and 225." | 2.58 | Photodynamic treatment outcomes of potentially-malignant lesions and malignancies of the head and neck region: A systematic review. ( Choudhary, MG; Gadbail, AR; Gondivkar, SM; Likhitkar, MS; Vedpathak, PR, 2018) |
| "They included squamous cell carcinoma (SCC), basal cell carcinoma (BCC), Bowen's disease (BD), mammary and extramammary Paget disease, actinic keratosis (AK) and erythroplasia of Queyrat." | 1.35 | Treatment of skin cancer and pre-cancer using topical ALA-PDT--a single hospital experience. ( Guo, MX; Wang, HW; Wang, XL; Xu, SZ, 2008) |
| "So far, we have treated 76 cases of skin cancer and pre-cancer using topical ALA-PDT." | 1.35 | Treatment of skin cancer and pre-cancer using topical ALA-PDT--a single hospital experience. ( Guo, MX; Wang, HW; Wang, XL; Xu, SZ, 2008) |
| "Erythroplasia of Queyrat (EQ) is an intraepithelial carcinoma in situ affecting the mucosal surfaces of the penis, with a significant risk of invasion and metastasis." | 1.30 | Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy. ( Ash, DV; Robinson, DJ; Stables, GI; Stringer, MR, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gondivkar, SM | 1 |
| Gadbail, AR | 1 |
| Choudhary, MG | 1 |
| Vedpathak, PR | 1 |
| Likhitkar, MS | 1 |
| Jia, QN | 1 |
| Nguyen, GH | 1 |
| Fang, K | 1 |
| Jin, HZ | 1 |
| Zeng, YP | 1 |
| Skroza, N | 1 |
| La Viola, G | 1 |
| Pampena, R | 1 |
| Proietti, I | 1 |
| Bernardini, N | 1 |
| Tolino, E | 1 |
| Annetta, A | 1 |
| Zuber, S | 1 |
| Balduzzi, V | 1 |
| Potenza, C | 1 |
| Wang, XL | 1 |
| Wang, HW | 1 |
| Guo, MX | 1 |
| Xu, SZ | 1 |
| Yu, CH | 2 |
| Lin, HP | 2 |
| Chen, HM | 2 |
| Yang, H | 2 |
| Wang, YP | 2 |
| Chiang, CP | 2 |
| Feldmeyer, L | 1 |
| Krausz-Enderlin, V | 1 |
| Töndury, B | 1 |
| Hafner, J | 1 |
| French, LE | 1 |
| Hofbauer, GF | 1 |
| Fai, D | 1 |
| Romano, I | 1 |
| Cassano, N | 1 |
| Vena, GA | 1 |
| Park, JY | 1 |
| Kim, SJ | 1 |
| Kim, YC | 1 |
| Lee, MR | 1 |
| Ryman, W | 1 |
| Stables, GI | 1 |
| Stringer, MR | 1 |
| Robinson, DJ | 1 |
| Ash, DV | 1 |
| Varma, S | 1 |
| Holt, PJ | 1 |
| Anstey, AV | 1 |
1 review available for aminolevulinic acid and Erythroplasia
| Article | Year |
|---|---|
Photodynamic treatment outcomes of potentially-malignant lesions and malignancies of the head and neck region: A systematic review.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Chlorophyllides; Databases, Factual; Dihematoporphyri | 2018 |
1 trial available for aminolevulinic acid and Erythroplasia
| Article | Year |
|---|---|
Comparison of clinical outcomes of oral erythroleukoplakia treated with photodynamic therapy using either light-emitting diode or laser light.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Erythroplasia; Female; Follow-Up Studies; Human | 2009 |
10 other studies available for aminolevulinic acid and Erythroplasia
| Article | Year |
|---|---|
Development of squamous cell carcinoma from erythroplasia of Queyrat following photodynamic therapy.
Topics: Aged; Aminolevulinic Acid; Carcinoma, Squamous Cell; Disease Progression; Erythroplasia; Humans; Mal | 2018 |
Erythroplasia of Queyrat treated with methyl aminolevulinate-photodynamic therapy.
Topics: Aged; Aminolevulinic Acid; Erythroplasia; Humans; Male; Penile Diseases; Photochemotherapy; Photosen | 2020 |
Treatment of skin cancer and pre-cancer using topical ALA-PDT--a single hospital experience.
Topics: Administration, Topical; Adult; Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Carcinoma, Squamou | 2008 |
Topical photodynamic therapy is very effective for oral verrucous hyperplasia and oral erythroleukoplakia.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Biopsy; Carcinoma in Situ; Erythroplasia; Femal | 2010 |
Methylaminolaevulinic acid photodynamic therapy in the treatment of erythroplasia of Queyrat.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminolevulinic Acid; Erythroplasia; Follow-Up Stud | 2011 |
Methyl-aminolevulinate photodynamic therapy for the treatment of erythroplasia of Queyrat in 23 patients.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Squamous Cell; Erythroplasia; Humans | 2012 |
Erythroplasia of Queyrat refractory to photodynamic therapy.
Topics: Aminolevulinic Acid; Erythroplasia; Humans; Male; Middle Aged; Penile Neoplasms; Photochemotherapy; | 2012 |
Erythroplasia of Queyrat treated with topical methyl aminolevulinate photodynamic therapy.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Squamous Cell; Ery | 2005 |
Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Carcinoma in Situ; Erythroplasia; Humans; Male; | 1999 |
Erythroplasia of queyrat treated by topical aminolaevulinic acid photodynamic therapy: a cautionary tale.
Topics: Adult; Aminolevulinic Acid; Carcinoma, Squamous Cell; Erythroplasia; Humans; Male; Penile Neoplasms; | 2000 |